No Data
No Data
JonesTrading Maintains Chimerix(CMRX.US) With Hold Rating, Maintains Target Price $8.55
Chimerix Hold Rating: Financial Constraints and Revised EPS Outlook Influence Cautious Recommendation
Catalyst Watch: Nvidia Event Could Revive Animal Spirits, Fed Meeting, and Nike Earnings
Why Chimerix, Inc. (CMRX) Soared Last Week
The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)